A polydopamine nanomedicine used in photothermal therapy for liver cancer knocks down the anti-cancer target NEDD8-E3 ligase ROC1 (RBX1)
Abstract Knocking down the oncogene ROC1 with siRNA inhibits the proliferation of cancer cells by suppressing the Neddylation pathway. However, methods for delivering siRNA in vivo to induce this high anticancer activity with low potential side effects are urgently needed. Herein, a folic acid (FA)-...
Main Authors: | Zhanxia Zhang, Junqian Zhang, Jianhui Tian, Hegen Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-10-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-021-01063-4 |
Similar Items
-
Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions
by: Dong-Jun Fu, et al.
Published: (2023-07-01) -
Neddylation inhibitor MLN4924 suppresses cilia formation by modulating AKT1
by: Hongmei Mao, et al.
Published: (2019-03-01) -
Establishment and Characterization of an Empirical Biomarker SS/PV-ROC Plot Using Results of the UBC<sup>®</sup> <i>Rapid</i> Test in Bladder Cancer
by: Peter Oehr, et al.
Published: (2020-06-01) -
ROC-ANALYSIS OF NEUROIMMUNOLOGIC INDICES IN PATIENTS WITH CHRONIC PSYCHOGENIC URTICARIA
by: E. A. Orlova
Published: (2012-05-01) -
Covariate Adjusted ROC Curve Analysis and An Application
by: Cengiz Bal, et al.
Published: (2015-12-01)